Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma Group (MREO) Debt Ratio: 2020-2022

  • Mereo BioPharma Group's Debt Ratio fell 94.48% to 0.01 in Q4 2022 from the same period last year, while for Dec 2022 it was 0.01, marking a year-over-year decrease of 94.48%. This contributed to the annual value of 0.01 for FY2022, which is 94.48% down from last year.
  • Per Mereo BioPharma Group's latest filing, its Debt Ratio stood at 0.01 for Q4 2022, which was up 4,151.83% from 0.00 recorded in Q2 2022.
  • In the past 5 years, Mereo BioPharma Group's Debt Ratio registered a high of 0.26 during Q4 2020, and its lowest value of 0.00 during Q2 2022.
  • Over the past 3 years, Mereo BioPharma Group's median Debt Ratio value was 0.12 (recorded in 2020), while the average stood at 0.11.
  • As far as peak fluctuations go, Mereo BioPharma Group's Debt Ratio grew by 0.21% in 2021, and later slumped by 99.89% in 2022.
  • Quarterly analysis of 3 years shows Mereo BioPharma Group's Debt Ratio stood at 0.26 in 2020, then crashed by 56.75% to 0.11 in 2021, then slumped by 94.48% to 0.01 in 2022.
  • Its last three reported values are 0.01 in Q4 2022, 0.00 for Q2 2022, and 0.11 during Q4 2021.